• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Minutia

Wednesday, June 05, 2024
Start-Up Stadium Session
Cell and Gene Therapy and Genome Editing
Company Description: Minutia is developing a regenerative medicine platform that improves safety and success outcomes of transplanted cells, our first therapy is a functional cure for Type 1 and Insulin Dependent Type 2 Diabetes with a simple outpatient procedure. We have already successfully demonstrated our out-patient transplant procedure in a PI-led Phase 1/2 clinical trial at UCSF, and are progressing our nanoparticle instrumented stem cell platform to enable safety and personalization across the broader cell therapy market.

Minutia
Company Website: http://www.minutia.co

Company HQ City

Oakland

Company HQ State

California

Company HQ Country

United States

CEO/Top Company Official

Katy Digovich
Primary Speaker
Katy Digovich, MBA
CEO
Minutia
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS